Company Overview of AnaptysBio, Inc.
AnaptysBio, Inc., an antibody development company, engages in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology in the Unites states. It is developing ANB020, a pro-inflammatory cytokine antibody that inhibits the activity of interleukin-33; and ANB019, an antibody that inhibits the function of the interleukin-36-receptor. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was founded in 2005 and is based in San Diego, California.
10421 Pacific Center Court
San Diego, CA 92121
Founded in 2005
Key Executives for AnaptysBio, Inc.
AnaptysBio, Inc. Key Developments
Similar Private Companies By Industry
|Biomira USA Inc.||United States|
|APSE, LLC||United States|
|Intellia Therapeutics Inc.||United States|
|DEW Technologies, Inc.||United States|
|Applied Catheter Technologies, Inc.||United States|
Recent Private Companies Transactions
July 13, 2015
To contact AnaptysBio, Inc., please visit www.anaptysbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.